Nippon India Nifty Pharma Etf Datagrid
Category Other ETFs
BMSMONEY Rank 4
Rating
Growth Option 16-06-2026
NAV ₹24.8(R) -0.26% (D) %
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 10.27% 22.8% -% -% -%
Direct
Benchmark
SIP (XIRR) Regular 13.79% 14.11% -% -% -%
Direct
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
0.98 0.52 0.92 -% -
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
16.82% -18.91% -15.21% - 11.93%
Fund AUM As on: 30/12/2025 1019 Cr

NAV Date: 16-06-2026

Scheme Name NAV Rupee Change Percent Change
Nippon India Nifty Pharma ETF 24.8
-0.0600
-0.2600%

Review Date: 16-06-2026


Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -2.36
1.78
-7.06 | 8.84 234 | 261 Poor
3M Return % 7.20
6.04
-6.50 | 31.20 96 | 261 Good
6M Return % 7.17
-1.80
-90.72 | 35.04 34 | 258 Very Good
1Y Return % 10.27
6.71
-90.50 | 130.59 36 | 228 Very Good
3Y Return % 22.80
11.92
-49.20 | 49.42 21 | 153 Very Good
1Y SIP Return % 13.79
3.95
-92.58 | 99.85 31 | 227 Very Good
3Y SIP Return % 14.11
6.38
-82.71 | 68.54 23 | 152 Very Good
Standard Deviation 16.82
18.16
0.00 | 68.30 77 | 134 Average
Semi Deviation 11.93
13.87
0.00 | 56.24 61 | 134 Good
Max Drawdown % -15.21
-21.82
-93.12 | 0.00 37 | 134 Good
VaR 1 Y % -18.91
-22.57
-39.69 | 0.00 29 | 134 Very Good
Average Drawdown % -6.41
-8.96
-48.21 | 0.00 44 | 134 Good
Sharpe Ratio 0.98
-1.15
-120.12 | 2.82 11 | 132 Very Good
Sterling Ratio 0.92
0.46
-0.50 | 1.30 16 | 134 Very Good
Sortino Ratio 0.52
0.23
-1.00 | 2.76 15 | 134 Very Good
Return data last Updated On : June 16, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : March 30, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
Standard Deviation 16.82 18.16 0.00 | 68.30 77 | 134 Average
Semi Deviation 11.93 13.87 0.00 | 56.24 61 | 134 Good
Max Drawdown % -15.21 -21.82 -93.12 | 0.00 37 | 134 Good
VaR 1 Y % -18.91 -22.57 -39.69 | 0.00 29 | 134 Very Good
Average Drawdown % -6.41 -8.96 -48.21 | 0.00 44 | 134 Good
Sharpe Ratio 0.98 -1.15 -120.12 | 2.82 11 | 132 Very Good
Sterling Ratio 0.92 0.46 -0.50 | 1.30 16 | 134 Very Good
Sortino Ratio 0.52 0.23 -1.00 | 2.76 15 | 134 Very Good
Return data last Updated On : June 16, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : March 30, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Nippon India Nifty Pharma Etf NAV Regular Growth Nippon India Nifty Pharma Etf NAV Direct Growth
16-06-2026 24.8001 None
15-06-2026 24.8641 None
12-06-2026 25.0285 None
11-06-2026 24.9537 None
10-06-2026 24.8039 None
09-06-2026 24.9369 None
08-06-2026 24.7908 None
05-06-2026 24.8942 None
04-06-2026 24.8019 None
03-06-2026 24.7084 None
02-06-2026 24.6262 None
01-06-2026 24.8395 None
29-05-2026 24.9748 None
27-05-2026 25.3499 None
26-05-2026 25.2918 None
25-05-2026 25.3079 None
22-05-2026 25.205 None
21-05-2026 25.5302 None
20-05-2026 25.4814 None
19-05-2026 25.5064 None
18-05-2026 25.3993 None

Fund Launch Date: 02/Jul/2021
Fund Category: Other ETFs
Investment Objective: The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the Nifty Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.
Fund Description: An open ended scheme replicating/ tracking NIFTY Pharma Index
Fund Benchmark: Nifty Pharma Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.